WARSAW, Ind., August 20, 2024 (GLOBE NEWSWIRE) – OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, today announced plans to hold an Investor Day on September 12, 2024 at 10:30 a.m. ET in New York, New York. The management presentation will provide updates on the Company’s specialty orthotics business strategy, product pipeline and financial outlook and will include a KOL surgeon panel.

Investors wishing to attend the event may register by contacting Investor Relations at [email protected] by September 6, 2024. The presentation will also be webcast live and a replay will be available in the Events & Presentations section of the Investor Relations website at www.orthopediatrics.com.

About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering for the pediatric orthopedics market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets 71 products serving three of the largest categories of the pediatric orthopedics market. This product offering includes trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization focuses exclusively on pediatric orthopedics and distributes its products in the United States and over 71 countries outside the United States. For more information, visit www.orthopediatrics.com.

Contact for investors
Philippe Trip-Taylor
Gilmartin Group
[email protected]
415-937-5406